Health

  • Sofie Pollet: An Heiress with Over 165 Million Euros and an Innovative Vision for the Pollet Group

    Sofie Pollet, heiress to the Pollet Group, manages a fortune of over 165 million euros, overseeing the diversified activities of the family business. Specializing in water treatment, swimming pools and healthcare, the Pollet Group has evolved under her leadership, while remaining a key player in these industries. With companies throughout Europe, the Middle East and Africa, Sofie Pollet continues to strengthen the family heritage while bringing a modern and innovative vision for the future.

  • Marc Coucke: The Belgian strategist behind a fortune of 1.25 billion euros

    Marc Coucke, Belgian billionaire with an estimated fortune of over 1.25 billion euros, is the epitome of successful entrepreneurship. From the founding of Omega Pharma to his varied investments in sport, leisure and healthcare, Coucke continues to make his mark on the Belgian and international business landscape in 2024.

  • Rudi Mariën: Biotechnology visionary with assets of over €200 million

    Rudi Mariën, a Belgian pharmacist and entrepreneur, has played a decisive role in the development of biotechnology in Belgium. Founder of Innogenetics and a key investor in numerous biotech companies, Mariën has accumulated assets of over 200 million euros. His commitment to innovation and technological development, notably through projects such as Tech Lane Ghent, continues to inspire the biotech sector worldwide.

  • Declerck-Allegaert Family: From Family Laboratory to an Empire Worth Over 37 Million Euros

    The Declerck-Allegaert family, founders of Klinisch Laboratorium Declerck, have transformed a local business into a major player in healthcare services in Flanders. With advanced technologies and rapid medical results, this laboratory gained notoriety, culminating in its acquisition by Australian giant Sonic Healthcare in 2015. Today, with assets of over 37 million euros, the family continues to stand out for its commitment to the community and quality of care.

  • Louis Ide: From Medicine to Politics, a Fortune of 8 Million Euros in the Service of Belgium

    Louis Ide, Belgian doctor and politician, embodies the alliance between medical expertise and political commitment. An influential member of the N-VA, he made a name for himself as a senator while pursuing a career in tropical medicine and clinical biology. With a fortune estimated at over 8 million euros, Louis Ide continues to play a key role in legislative debates and actively contributes to public health and Belgian society. Find out how this man of many talents balances his political, medical and family responsibilities.

  • The Janssen Family Dynasty: Secular Influence and a 3-Billion-Euro Fortune

    The Janssen family, one of Belgium's most influential dynasties, has positioned itself at the heart of the banking, industrial and pharmaceutical sectors. With assets estimated at over 3 billion euros, their legacy is marked by strategic alliances, notably with the Solvay group and UCB, and by rigorous management of their assets. From Daniel Janssen to Charles-Antoine Janssen, each generation has strengthened the family's grip on the Belgian economy. Discover how this family has combined tradition, innovation and strategy to become one of Belgium's wealthiest.

  • Dr. Paul Janssen: The Visionary Entrepreneur Behind a 300 Million Euro Fortune and a Pharmaceutical Legacy

    Dr. Paul Janssen, founder of Janssen Pharmaceutica, is one of the most influential figures in the Belgian pharmaceutical industry. With a legacy estimated at over 300 million euros, Janssen revolutionized medicine with innovative medicines, while remaining a central figure in the company after its takeover by Johnson & Johnson. In addition to his medical contributions, he left a significant cultural imprint, with a unique collection of pre-Columbian art. Discover how this visionary built a pharmaceutical empire while influencing Belgian art and economics.

  • De Raedt-Verheyden family: Colossal 1.7-billion-euro empire in biotechnology

    Gino De Raedt and Frederica Verheyden have built a financial empire estimated at over 1.7 billion euros, from a simple medical laboratory in 1978 to major players in European biotechnology. Their journey, marked by strategic acquisitions and a spectacular merger with Biogroup, illustrates an exceptional entrepreneurial vision. With record dividends and diversified investments in real estate and private equity, the De Raedt-Verheyden couple have become one of Belgium's largest fortunes, while preparing for the future with their daughter Ann. Their story embodies the perfect blend of scientific innovation and financial genius.